Skip to main content

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

Publication ,  Journal Article
VanderWalde, N; Jagsi, R; Dotan, E; Baumgartner, J; Browner, IS; Burhenn, P; Cohen, HJ; Edil, BH; Edwards, B; Extermann, M; Ganti, AKP ...
Published in: J Natl Compr Canc Netw
November 2016

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2016

Volume

14

Issue

11

Start / End Page

1357 / 1370

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Aged, 80 and over
  • Aged
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
VanderWalde, N., Jagsi, R., Dotan, E., Baumgartner, J., Browner, I. S., Burhenn, P., … Hurria, A. (2016). NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw, 14(11), 1357–1370. https://doi.org/10.6004/jnccn.2016.0146
VanderWalde, Noam, Reshma Jagsi, Efrat Dotan, Joel Baumgartner, Ilene S. Browner, Peggy Burhenn, Harvey Jay Cohen, et al. “NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.J Natl Compr Canc Netw 14, no. 11 (November 2016): 1357–70. https://doi.org/10.6004/jnccn.2016.0146.
VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, et al. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 Nov;14(11):1357–70.
VanderWalde, Noam, et al. “NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.J Natl Compr Canc Netw, vol. 14, no. 11, Nov. 2016, pp. 1357–70. Pubmed, doi:10.6004/jnccn.2016.0146.
VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AKP, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O’Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 Nov;14(11):1357–1370.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2016

Volume

14

Issue

11

Start / End Page

1357 / 1370

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Aged, 80 and over
  • Aged
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis